Match Funding Appeal
MAKING A SIGNIFICANT IMPACT TO HEAD & NECK CANCER RESEARCH
This year Oracle Head & Neck Cancer UK has an extraordinary opportunity to make a significant impact in the field of head and neck cancer research through an amazing Match Funding Appeal:
- Matching Offer: A UK family foundation has generously pledged to match donations pound for pound, up to a total of £150,000.
- Eligibility: Donations of £1,000 or more qualify for this matching scheme.
- Deadline: This exclusive opportunity is available until December 20, 2024.
- Impact: Your contribution will be doubled, allowing us to fund ground-breaking medical research projects in head and neck cancer.
- Context: Head and neck cancer cases are projected to increase by 30% annually by 2030, yet it receives only 1% of Cancer Research UK’s cancer-specific research funding.
- Our Goal: To secure the full £150,000 in matched funding to advance vital research and improve patient outcomes.
A UNIQUE CHANCE TO TRANSFORM HEAD & NECK CANCER RESEARCH
This time-limited opportunity allows donors to double the impact of their generosity. Whether you contribute £1,000 (which becomes £2,000) or £50,000 (which transforms into £100,000), your donation will play a crucial role in closing the critical funding gap in head and neck cancer research.
To participate in this appeal or for more information, please email us at finance@oraclehnc.org.uk. We will promptly send you a pledge form and our bank details, and address any questions you may have.
HEAD AND NECK CANCER IS A GROWING THREAT
With cases expected to increase by 30% annually by 2030. Yet it receives only 1% of CRUK cancer-specific research funding. Your matched donation can help close this critical gap.
Oracle Head & Neck Cancer UK has secured an extraordinary opportunity to double the impact of your generosity. A UK family foundation has pledged to match donations up to £150,000 towards ground-breaking medical research projects in head and neck cancer.
ACT NOW
DON’T MISS THIS CHANCE TO DOUBLE YOUR IMPACT.
This is a time-limited opportunity to make your contribution go twice as far. By acting before December 20, 2024, you can play a pivotal role in advancing head and neck cancer research and improving patient outcomes.
Donate today and help us secure the full £150,000 in matched funding for vital research. How to join our match funding appeal:
Cancer Care: Why Mental Health Support Must Be Part of Every Cancer Journey
Oracle Head & Neck Cancer UK is proud to support the Daily Express Cancer Care campaign, a powerful series that shines a light on the often unseen emotional toll of cancer – and the urgent need for better psychological support for everyone affected. The campaign published over the past three weeks featured voices from across…
Ground-breaking blood test shows promise for early detection of head & neck and other hard-to-screen cancers
A new large-scale trial has found that the blood-based screening test known as Galleri test can detect more than 50 types of cancer – including cancers of the head and neck, which currently have no routine screening programme – and may significantly boost early diagnosis. The trial showed that, when used alongside existing screening methods,…
2 Minutes to Save Your Life: Oracle Launches HeadNeckCheck Campaign for Make Sense Week
This Make Sense Week (15-20 September), the European-wide head and neck cancer awareness initiative, Oracle Head & Neck Cancer UK, is championing both prevention and early detection – recognising that stopping cancer before it starts is just as vital as catching it early. Two Ways to Fight Cancer This Week Prevention Today: Head and neck…
Leadership update
After four successful years as CEO, Tamara Kahn has transformed Oracle into a respected national voice for head and neck cancer patients. She established a national presence, created a four-pillar RACE strategy (Research, Awareness, Collaboration and Patient/Community Engagement) and built strong policy influence. With these foundations now firmly in place, Tamara will transition from her…
Finding Light in Adversity: Seven inspiring stories through head and neck cancer
A new collection of patient stories from Oracle Head and Neck Cancer UK reveals how individuals facing head and neck cancer have discovered unexpected sources of strength, purpose and even joy during their treatment and recovery. The seven contributors share remarkably similar themes despite their unique journeys. Almost all emphasise the power of maintaining a…
NHS to fast-track patients with head and neck cancer into cancer vaccine trial
Patients with advanced head and neck cancers in England will be fast-tracked into a trial of a new cancer vaccine, as the NHS expands its world-leading trial ‘match-making’ service. The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus proteins. More than 100 patients with advanced head…
World Head and Neck Cancer Awareness Day 2025: The HPV Vaccine Could Save Your Life
27th July 2025 This World Head and Neck Cancer Awareness Day, Oracle Head and Neck Cancer UK has a simple but urgent message: HPV vaccination saves lives. With HPV-related head and neck cancers having doubled in the past 20 years, the charity is using today to remind the public that these devastating cancers are preventable…
Data from the National Disease Registration Service on HPV associated and HPV independent oropharyngeal squamous cell carcinoma
The Get Data Out Programme from the National Disease Registration Service (NDRS), part of NHS England, has published statistics on incidence, routes to diagnosis and treatment for patients diagnosed with oropharyngeal cancer in England by human papillomavirus (HPV) status. To our knowledge this is the first time data on oropharyngeal cancer by HPV status has…
Join Us for an Evening of Research, Impact, and Conversation
Research & Impact EveningDate: Monday 28th April 2025Time: 6:00 PM – 8:30 PMVenue: Skyline, Tower Suites, 100 Minories, London EC3N 1JY A Celebration of Research Join us for a meaningful and action-focused evening where we’ll be diving into some of the big conversations around head and neck cancer – especially those linked to HPV (human…
What the Rare Cancers Bill Means for Head & Neck Cancer
14 March marked a crucial moment for research into rare cancers, as the Rare Cancers Bill took another significant step toward becoming law! Dr. Scott Arthur, a Labour MP, introduced this legislation in Parliament to drive much-needed research into cancers affecting fewer than 1 in 2000 people in the UK – including many types of…
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.